PYRROLIDINE ETHER DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS
申请人:Jablonski Philippe
公开号:US20090306043A1
公开(公告)日:2009-12-10
The present invention relates to compounds of formula I
wherein R
1
, R
2
, R
3
, R′, Ar, m, n, and o are as defined herein. The invention also relates to pharmaceutical compositions containing compounds of formula I and methods for the manufacture of such compounds and compositions. Compounds of the invention are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).